FDA vaccines chief Vinay Prasad to leave regulator in April - Reuters
FDA vaccines chief Vinay Prasad to leave regulator in April Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"He got a tremendous amount accomplished within his one-year sabbatical from UCSF and will be returning back to his academic home later next month."
— Marty Makary , Executive
"Prasad would now return to his teaching position at the University of California San Francisco, framing his FDA work as part of a 'one-year sabbatical' from academia."
— Marty Makary , Executive
"FDA Commissioner Dr. Marty Makary has not made a decision on a replacement to lead the agency’s Center for Biologics Evaluation and Research."
— Marty Makary , Executive
Key People
Former president of the United States known for his aggressive economic policies.
Laura Loomer is a far-right political activist and social media influencer.
Marty Makary is the FDA commissioner who announced Prasad's departure.
Robert F Kennedy Jr is the HHS secretary and a longtime vaccine skeptic.
Robert F. Kennedy Jr. is an American environmental attorney and activist.
Vinay Prasad is the FDA vaccines chief.
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeXgyU28teEVyR0tIazhyWE9KRnpwQ2dQMnJnVWxUY3VhWlVaMjVLdnhxS0RJOVBPSVU1VmNEOVhpZWk5SFloY2NIVlZIUldiWW8wWHpWemMzaXhUQ05mSERPVlZpVWp3bzFvZHBON2lhSkU0N2RTQ3g1el9fOWstNTJXLTA4a1NlOGVqajVBTWFXUEFlR0lKRXA2V3cwc0U2b1ZIUi1pdGFKVkJrMVFYT3NSTlM3MEd1VlJZ?oc=5" target="_blank">FDA vaccines chief Vinay Prasad to leave regulator in April</a> <font color="#6f6f6f">Reuters</font>
Vinay Prasad, the FDA's top vaccine regulator, is set to leave the agency at the end of April, returning to his academic position at the University of California, San Francisco.
Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, will depart at the end of April, returning to his academic role at the University of California, San Francisco.
Dr. Vinay Prasad, head of the FDA's vaccines and biologic medicines division, will leave the agency at the end of April, returning to his academic position at the University of California, San Francisco.
Dr. Vinay Prasad is leaving the FDA for the second time in less than a year, following controversial decisions involving vaccine reviews and specialty drugs for rare diseases.
Embattled FDA regulator Vinay Prasad will leave the agency next month, following recent controversies over vaccine approvals and gene therapies.
Similar Stories
Related coverage based on topic and tags
OpenAI's AGI deployment chief Fidji Simo to step down after medical leave - Reuters
OpenAI's AGI deployment chief Fidji Simo to step down after medical leave Reuters
July 9, 2026 at 11:23 PMIndia's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026 at 12:23 PMInside RFK Jr.’s push to dismantle decades of U.S. vaccine policy - Reuters
Inside RFK Jr.’s push to dismantle decades of U.S. vaccine policy Reuters
July 14, 2026 at 12:58 PMUS FDA approves Vera's kidney disease drug - Reuters
US FDA approves Vera's kidney disease drug Reuters
July 7, 2026 at 05:09 PMUS FDA urges infant-formula makers to tighten supplier oversight after product recalls, botulism outbreaks - Reuters
US FDA urges infant-formula makers to tighten supplier oversight after product recalls, botulism outbreaks Reuters
July 13, 2026 at 06:53 PMFed's Warsh to appear before Congress after tentative steps away from Trump - Reuters
Fed's Warsh to appear before Congress after tentative steps away from Trump Reuters
July 14, 2026 at 12:32 PM